أعرض في EDS

Ultrasound-guided measurement of skin and subcutaneous tissue thickness in children with diabetes and recommendations for giving insulin injections

التفاصيل البيبلوغرافية
العنوان: Ultrasound-guided measurement of skin and subcutaneous tissue thickness in children with diabetes and recommendations for giving insulin injections
المؤلفون: Pei Kwee Lim, Chin Choo Evelyn Lim, Rashida Farhad Vasanwala, Yuen Ching Angela Hui, Yen Yen Chia, Soo Ting Lim
المصدر: Journal of Clinical & Translational Endocrinology, Vol 12, Iss C, Pp 26-35 (2018)
Journal of Clinical & Translational Endocrinology
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: medicine.medical_specialty, lcsh:RC648-665, business.industry, Endocrinology, Diabetes and Metabolism, Insulin, medicine.medical_treatment, Ultrasound, 030209 endocrinology & metabolism, Lower risk, medicine.disease, lcsh:Diseases of the endocrine glands. Clinical endocrinology, Surgery, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, medicine.anatomical_structure, Diabetes mellitus, medicine, Abdomen, 030212 general & internal medicine, Buttocks, Intramuscular injection, business, Research Paper, Subcutaneous tissue
الوصف: Aim To measure skin thickness (ST) and skin + subcutaneous layer thickness (SCT) by ultrasound and estimate the risk of intramuscular injection (IM) with different needle lengths across injection sites according to age group. Method Children recruited between 1 and 18 years with type 1 and 2 diabetes on insulin injections and divided into three age groups: 1–6 years, 7–12 years and 13–18 years. A portable ultrasound was used to measure ST and SCT at four injection sites on the abdomen, arm, thigh and buttock. Results Total 153 children enrolled for the study. The mean (SD) measurement of ST & SCT at four sites on abdomen, arm, thigh & buttocks were as follows; 4.33 mm (±2.22), 5.55 mm (±2.26), 5.83 mm (±3.12), 6.48 mm (±3.47) in 1–6 years old; 7.11 mm (±3.68), 7.79 mm (±4.54), 7.17 mm (±3.62), 8.51 mm (±3.65) in 7–12 years old; 8.94 mm (±4.50), 8.42 mm (±5.00), 8.61 mm (±4.76), 9.76 mm (±4.38) in 13–18 years old. Young children, 1–6 years have the highest risk of IM injection with all needle lengths, i.e. 4, 5, 6, 8 & 12.7 mm, while older children 7–12 & 13–18 years have a lower risk with shorter needles (4, 5 and 6 mm) as compared to longer needles (8 and 12.7 mm). Conclusions Children with diabetes on insulin therapy should be advised on the appropriate needle length accordingly to their age and BMI.
تدمد: 2214-6237
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d50a95ee64cf67a5d86494360b4e32
https://doi.org/10.1016/j.jcte.2018.04.004
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....b5d50a95ee64cf67a5d86494360b4e32
قاعدة البيانات: OpenAIRE
الوصف
تدمد:22146237